- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/06 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 223/06
Total number of patents in this class: 56
10-year publication summary
|
2
|
5
|
3
|
9
|
6
|
3
|
3
|
2
|
4
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Inflazome Limited | 85 |
5 |
| Biogen MA Inc. | 914 |
4 |
| The University of Melbourne | 551 |
4 |
| The Scripps Research Institute | 1355 |
3 |
| West China Hospital, Sichuan University | 206 |
3 |
| Bristol-myers Squibb Company | 4826 |
2 |
| The Regents of the University of California | 20303 |
2 |
| Novira Therapeutics, Inc. | 32 |
2 |
| Ono Pharmaceutical Co., Ltd. | 428 |
2 |
| Richter Gedeon Nyrt. | 1635 |
2 |
| Vironova Thionation AB | 5 |
2 |
| Horizon Orphan LLC. | 32 |
2 |
| Elevatebio Technologies, Inc. | 26 |
2 |
| Novartis AG | 10612 |
1 |
| F. Hoffmann-La Roche AG | 7937 |
1 |
| Hoffmann-La Roche Inc. | 3546 |
1 |
| Takeda Pharmaceutical Company Limited | 2721 |
1 |
| Korea Institute of Science and Technology | 2157 |
1 |
| ACADIA Pharmaceuticals Inc. | 199 |
1 |
| Actelion Pharmaceuticals Ltd | 528 |
1 |
| Other owners | 14 |